Masters of Science in Biotechnology - Cell and Gene Therapy

Biotechnology is a dominant sector of the global economy. Advances fueled by the biotechnology industry have revolutionized health care, agriculture and environmental remediation in the 21st century. Over the past several decades there have been major expansions in the field of biotechnology, which has affected many aspects of our lives and society.

The Department of Biochemistry and Molecular Biology offers a program of study leading to the M.S. degree in Biotechnology, whose curriculum reflects the multidisciplinary nature of biotechnology, integrating theoretical and lab-based science courses with dedicated courses in BioBusiness, intellectual property, entrepreneurship, regulatory affairs, etc. The oneyear (30-credit) program may be completed over a longer time frame for students who are already employed or wish to complete the program on a part-time basis. The M.S. offers five different tracks.

The Cell & Gene Therapy Track focuses on the most recent important approaches to bring new individualized treatments to oncology and rare diseases.

Biotechnology plays a crucial role in developing targeted approaches. This tremendous shift from small molecules to biologics and now to cell and gene therapy involves a paradigm shift from treatment to cure. This track helps students to understand this trajectory, and equips them with the most current knowledge to take advantage of incredible new opportunities.